<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: advisory panel</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Primary care docs should play role in kids' dental health, experts say</title>
   	 <description>(HealthDay)—When it comes to the care of your children's teeth, dentists aren't the only experts who can help.</description>
	  <link>http://medicalxpress.com/news/2013-05-primary-docs-role-kids-dental.html</link>
	 <category>Dentistry</category>
	 <pubDate>Tue, 21 May 2013 07:20:01 EST</pubDate>
	 <guid isPermaLink="false">news288336885</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/2-primarycared.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel to consider brain stimulator for epilepsy</title>
   	 <description>(HealthDay News) - A U.S. Food and Drug Administration advisory panel will weigh on Friday the merits of a new therapy for some people with epilepsy who have seizures that don't respond to medication.</description>
	  <link>http://medicalxpress.com/news/2013-02-fda-panel-brain-epilepsy.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 21 Feb 2013 13:50:01 EST</pubDate>
	 <guid isPermaLink="false">news280673844</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fdapaneltoco.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel votes for tougher curbs on vicodin, other painkillers</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory panel voted Friday to place tougher restrictions on prescription painkillers containing hydrocodone, potentially moving medications such as Vicodin into the same class as narcotics such as Oxycontin and Percocet.</description>
	  <link>http://medicalxpress.com/news/2013-01-fda-panel-votes-tougher-curbs.html</link>
	 <category>Medications</category>
	 <pubDate>Sat, 26 Jan 2013 07:50:01 EST</pubDate>
	 <guid isPermaLink="false">news278401640</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-fdapanelvote.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel votes for tougher restrictions on hydrocodone</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory panel met Thursday and Friday to discuss the fate of certain painkillers that contain the opioid known as hydrocodone, concluding in a vote in favor of moving hydrocodone combination products into the more restrictive Schedule II category of controlled substances.</description>
	  <link>http://medicalxpress.com/news/2013-01-fda-panel-votes-tougher-restrictions.html</link>
	 <category>Medications</category>
	 <pubDate>Sat, 26 Jan 2013 06:20:01 EST</pubDate>
	 <guid isPermaLink="false">news278401574</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fdapanelvote.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel weighs tougher restrictions on some prescription painkillers</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory panel will meet Thursday and Friday to discuss the fate of certain  painkillers that contain an opioid known as hydrocodone.</description>
	  <link>http://medicalxpress.com/news/2013-01-fda-panel-tougher-restrictions-prescription.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 24 Jan 2013 16:20:01 EST</pubDate>
	 <guid isPermaLink="false">news278262973</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fdapanelweig.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists to resume work with lab-bred bird flu</title>
   	 <description>International scientists who last year halted controversial research with the deadly bird flu say they are resuming their work as countries adopt new rules to ensure safety.</description>
	  <link>http://medicalxpress.com/news/2013-01-scientists-resume-lab-bred-bird-flu.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 23 Jan 2013 15:09:54 EST</pubDate>
	 <guid isPermaLink="false">news278176188</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/staffcullchi.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel recommends against 1st drug for chronic fatigue syndrome</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.</description>
	  <link>http://medicalxpress.com/news/2012-12-fda-panel-1st-drug-chronic_1.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 21 Dec 2012 10:40:42 EST</pubDate>
	 <guid isPermaLink="false">news275308835</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapanelreco.jpg" width="90" height="90" />
</item>
<item>
     <title>Looking to NANA: Touch-screen technology to address malnutrition in older adults</title>
   	 <description>A touch-screen computer to help detect malnutrition in older adults has been created by a team of researchers led by the University of St Andrews.</description>
	  <link>http://medicalxpress.com/news/2012-11-nana-touch-screen-technology-malnutrition-older.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 08 Nov 2012 06:50:08 EST</pubDate>
	 <guid isPermaLink="false">news271579791</guid>
	 
</item>
<item>
     <title>Bird flu debate: Should H5N1 experiments resume?</title>
   	 <description>Virologists making mutated versions of the H5N1 bird flu halted their research in January after a U.S. government advisory panel suggested that their work, though well-intentioned, had the potential to endanger the public.</description>
	  <link>http://medicalxpress.com/news/2012-10-bird-flu-debate-h5n1-resume.html</link>
	 <category>Medical research</category>
	 <pubDate>Sat, 13 Oct 2012 09:10:59 EST</pubDate>
	 <guid isPermaLink="false">news269338236</guid>
	 
</item>
<item>
     <title>FDA recommends approval for Second Sight's Argus II retinal prosthesis system in the US</title>
   	 <description>On Friday September 28, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the Argus II Retinal Prosthesis System outweighs the risks to health, an important step toward the FDA market approval of this product manufactured by Second Sight Medical Products, Inc. In making this determination, the panel spent ten hours carefully reviewing and discussing data submitted from the international clinical trial of this innovative retinal implant that, for the first time ever, partially restores vision to patients who are blind due to Retinitis Pigmentosa (RP).</description>
	  <link>http://medicalxpress.com/news/2012-10-fda-sight-ii-retinal-prosthesis.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Wed, 03 Oct 2012 04:03:12 EST</pubDate>
	 <guid isPermaLink="false">news268455784</guid>
	 
</item>
<item>
     <title>9/11 WTC health program adds 50 types of cancer</title>
   	 <description>(AP)—The federal government will include about 50 types of cancer on the list of Sept. 11 World Trade Center-related illnesses covered by a program to pay for health coverage.</description>
	  <link>http://medicalxpress.com/news/2012-09-wtc-health-cancer.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 10 Sep 2012 16:56:27 EST</pubDate>
	 <guid isPermaLink="false">news266514977</guid>
	 
</item>
<item>
     <title>New guidelines say no to screening EKGs for low-risk patients</title>
   	 <description>(HealthDay) -- A top U.S. advisory panel has recommended against preventive electrocardiography (EKG) screening for people at low risk of heart disease.</description>
	  <link>http://medicalxpress.com/news/2012-07-guidelines-screening-ekgs-low-risk-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 30 Jul 2012 18:14:30 EST</pubDate>
	 <guid isPermaLink="false">news262890855</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-newguideline.jpg" width="90" height="90" />
</item>
<item>
     <title>US regulators to decide on new weight loss drug</title>
   	 <description> US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.</description>
	  <link>http://medicalxpress.com/news/2012-07-weight-loss-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 17 Jul 2012 12:52:13 EST</pubDate>
	 <guid isPermaLink="false">news261748312</guid>
	 
</item>
<item>
     <title>Older women should not take calcium, vitamin D: task force</title>
   	 <description>(HealthDay) -- A leading U.S. government advisory panel has proposed that postmenopausal women not take low-dose  calcium and vitamin D supplements daily to ward off bone fractures.</description>
	  <link>http://medicalxpress.com/news/2012-06-older-women-calcium-vitamin-d.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 12 Jun 2012 18:00:01 EST</pubDate>
	 <guid isPermaLink="false">news258741705</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/olderwomensh.jpg" width="90" height="90" />
</item>
<item>
     <title>New blood thinner may lower chances of clots in high-risk heart patients: FDA</title>
   	 <description>(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.</description>
	  <link>http://medicalxpress.com/news/2012-05-blood-thinner-chances-clots-high-risk.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 21 May 2012 21:30:01 EST</pubDate>
	 <guid isPermaLink="false">news256843717</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newbloodthin.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel backs first rapid, take home HIV test</title>
   	 <description>(AP) --  A panel of HIV specialists is recommending that U.S. regulators approve the first over-the-counter HIV test designed to quickly return a result in the privacy of a person's own home, a new option which could expand testing for the virus that causes AIDS.</description>
	  <link>http://medicalxpress.com/news/2012-05-fda-panel-rapid-home-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 15 May 2012 17:19:16 EST</pubDate>
	 <guid isPermaLink="false">news256321148</guid>
	 
</item>
<item>
     <title>FDA panel backs first pill to block HIV infection</title>
   	 <description>The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.</description>
	  <link>http://medicalxpress.com/news/2012-05-fda-panel-pill-block-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 11 May 2012 04:35:14 EST</pubDate>
	 <guid isPermaLink="false">news255929707</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapanelback.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA to decide on Qnexa obesity drug in July</title>
   	 <description> US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.</description>
	  <link>http://medicalxpress.com/news/2012-04-obesity-drug-july.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 10 Apr 2012 12:15:20 EST</pubDate>
	 <guid isPermaLink="false">news253278870</guid>
	 
</item>
<item>
     <title>FDA panel to weigh second chance for new class of painkillers</title>
   	 <description>(HealthDay) -- A U.S. Food and Drug Administration advisory panel on Monday will weigh the wisdom of allowing new clinical trials of a class of powerful painkillers for osteoarthritis. The drugs may have worked so well for some patients that those patients wound up needing knee replacement surgery because they overworked their already damaged joints.</description>
	  <link>http://medicalxpress.com/news/2012-03-fda-panel-chance-class-painkillers.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 12 Mar 2012 14:40:01 EST</pubDate>
	 <guid isPermaLink="false">news250778922</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapaneltowe.jpg" width="90" height="90" />
</item>
<item>
     <title>Government panel favors some WTC cancer claims</title>
   	 <description>(AP) --  A government panel favors expanding an aid program for people sickened by World Trade Center dust to include people who have at least some types of cancer.</description>
	  <link>http://medicalxpress.com/news/2012-02-panel-favors-wtc-cancer.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 16 Feb 2012 14:40:01 EST</pubDate>
	 <guid isPermaLink="false">news248624251</guid>
	 
</item>
<item>
     <title>Health experts, scientists to discuss bird flu studies</title>
   	 <description> The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.</description>
	  <link>http://medicalxpress.com/news/2012-02-health-experts-scientists-discuss-bird.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 10 Feb 2012 13:30:02 EST</pubDate>
	 <guid isPermaLink="false">news248102357</guid>
	 
</item>
<item>
     <title>Controversial research on bird flu</title>
   	 <description>In a top-security lab in the Netherlands, scientists guard specimens of a super-killer influenza that slays half of those it infects and spreads easily from victim to victim.</description>
	  <link>http://medicalxpress.com/news/2011-12-controversial-bird-flu_1.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 28 Dec 2011 03:43:48 EST</pubDate>
	 <guid isPermaLink="false">news244266218</guid>
	 
</item>
<item>
     <title>FDA approves Regeneron's eye injection Eylea</title>
   	 <description>(AP) --  Regulators on Friday approved Regeneron Pharmaceuticals Inc.'s drug Eylea, an injection designed to treat a common cause of blindness in older people.</description>
	  <link>http://medicalxpress.com/news/2011-11-fda-regeneron-eye-eylea.html</link>
	 <category>Medications</category>
	 <pubDate>Sat, 19 Nov 2011 11:25:44 EST</pubDate>
	 <guid isPermaLink="false">news240924324</guid>
	 
</item>
<item>
     <title>Gov't considers testing anthrax vaccine in kids</title>
   	 <description>A government advisory panel is considering whether the anthrax vaccine should be tested in children.</description>
	  <link>http://medicalxpress.com/news/2011-10-govt-anthrax-vaccine-kids.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 28 Oct 2011 13:20:17 EST</pubDate>
	 <guid isPermaLink="false">news239026802</guid>
	 
</item>


</channel>
</rss>
